Stock LLY ELI LILLY AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Eli Lilly and Company NEO Exchange

Equities

LLY

CA28655A1066

End-of-day quote NEO Exchange
Other stock markets
 18:00:00 2024-06-27 EDT 		5-day change 1st Jan Change
34.01 CAD -0.44% Intraday chart for Eli Lilly and Company +2.19% +54.31%
06-28 Atossa Therapeutics Doubles Z-Endoxifen Dose in Phase 2 Breast Cancer Study MT
06-28 EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older RE

Chart calendar Eli Lilly and Company

71b8261.prqJx7pPfFbnMEb2zV5hIzjYCdqGpPf6W-KHf0J00a0.4YK8pPELG2CJWiHApmtMT1nsYaj-nb2MCaa1IBQFnpzAjfGz7zUbOYEEEw~5bfb18c31490f04a1ed33b705156cf11

Upcoming events on Eli Lilly and Company

2024-08-08 06:25 Q2 2024 Earnings Release
2024-08-08 10:00 Q2 2024 Earnings Call
2024-10-30 06:25 Q3 2024 Earnings Release
2024-10-30 10:00 Q3 2024 Earnings Call
2025-01-29 Q4 2024 Earnings Release (Projected)
2025-04-23 Q1 2025 Earnings Release (Projected)
2025-08-04 Q2 2025 Earnings Release (Projected)
2025-11-03 Q3 2025 Earnings Release (Projected)

Past events on Eli Lilly and Company

2024-06-21 15:45 American Diabetes Association Scientific Symposium
2024-06-10 16:00 Goldman Sachs Global Healthcare Conference - Fireside Chat
2024-06-03 18:12 American Society of Clinical Oncology Meeting - Abstract Number: LBA507
2024-06-03 14:30 American Society of Clinical Oncology Meeting - Abstract Number: 8547
2024-06-03 10:00 American Society of Clinical Oncology Meeting - Abstract Number: 5589
2024-06-03 10:00 American Society of Clinical Oncology Meeting - Abstract Number: 11111
2024-06-03 10:00 American Society of Clinical Oncology Meeting - Abstract Number: 11068
2024-06-02 20:30 American Society of Clinical Oncology Meeting
2024-06-02 18:06 American Society of Clinical Oncology Meeting - Abstract Number: 10022
2024-06-02 10:00 American Society of Clinical Oncology Meeting - Abstract Number: 1027
2024-06-01 18:00 American Society of Clinical Oncology Meeting - Abstract Number: 3007
2024-06-01 16:12 American Society of Clinical Oncology Meeting - Abstract Number: 5001
2024-06-01 16:00 American Society of Clinical Oncology Meeting - Abstract Number: LBA1001
2024-06-01 14:39 American Society of Clinical Oncology Meeting - Abstract Number: 8510
2024-06-01 10:00 American Society of Clinical Oncology Meeting - Abstract Number: 3150
2024-05-14 Détachement de
2024-05-06 08:30 Annual General Meeting
2024-04-30 10:00 Q1 2024 Earnings Call
2024-04-30 06:45 Q1 2024 Earnings Release
2024-04-08 16:30 American Association for Cancer Research Meeting - Abstract Number: 3230

Past dividends on Eli Lilly and Company

2024-05-14 Quarterly 1.3 USD
2024-02-13 Quarterly 1.3 USD
2023-11-13 Quarterly 1.13 USD
2023-08-13 Quarterly 1.13 USD
2023-05-11 Quarterly 1.13 USD
2023-02-13 Quarterly 1.13 USD
2022-11-13 Quarterly 0.98 USD
2022-08-11 Quarterly 0.98 USD
2022-05-12 Quarterly 0.98 USD
2022-02-13 Quarterly 0.98 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		22 320
22 142
0.8%		24 540
24 394
0.6%		28 318
28 205
0.4%		28 541
28 641
-0.35%		34 124
33 585
1.6%
42 973

EBITDA
Million USD		Released
Forecast
Spread 		7 551
7 508
0.57%		8 589
8 676
-1.01%		10 005
9 767
2.43%		9 473
9 494
-0.23%		8 584
8 418
1.98%
16 230

EBIT
Million USD		Released
Forecast
Spread 		6 079
6 106
-0.44%		7 265
7 503
-3.17%		8 457
8 599
-1.65%		7 950
8 164
-2.62%		7 057
6 928
1.86%
14 683

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		5 266
8 975
-41.33%		7 230
7 041
2.68%		6 156
7 148
-13.88%		6 806
7 084
-3.93%		6 555
6 311
3.86%
13 749

Net income
Million USD		Released
Forecast
Spread 		8 318
8 090
2.83%		6 194
5 805
6.69%		5 582
6 019
-7.27%		6 245
6 102
2.35%		5 240
5 307
-1.26%
11 932

EPS
USD		Released
Forecast
Spread 		8,89
8,65
2.83%		6,79
6,36
6.69%		6,12
6,43
-4.75%		6,90
6,60
4.57%		5,80
6,04
-3.92%
13,4

Announcement Date30/01/2029/01/2103/02/2202/02/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		7 810
7 319
6.7%		6 488
6 854
-5.33%		6 942
6 901
0.58%		7 302
7 376
-1%		6 960
6 867
1.36%		8 312
7 590
9.51%		9 499
8 965
5.96%		9 353
8 971
4.27%		8 768
8 930
-1.81%
10 000


11 327


12 781


10 920


12 135

EBITDA
Million USD		Released
Forecast
Spread 		3 046
2 717
12.12%		1 679
2 387
-29.67%		2 373
2 385
-0.5%		2 375
2 268
4.72%		1 982
2 148
-7.73%		2 618
2 416
8.39%		986
3 460
-71.49%		2 855
3 517
-18.81%		3 049
2 827
7.84%
3 750


4 844


5 994







EBIT
Million USD		Released
Forecast
Spread 		2 610
2 336
11.74%		1 330
1 790
-25.7%		2 010
2 007
0.13%		2 000
1 953
2.41%		1 620
1 840
-11.95%		2 252
2 078
8.37%		575
921
-37.56%		2 468
2 448
0.79%		2 648
2 674
-0.96%
3 078


3 976


4 812







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread














2 089
2 107
-0.86%		427
-399
207.07%		2 509
1 248
101.03%		2 536
2 455
3.3%
3 000


3 878


4 497







Net income
Million USD		Released
Forecast
Spread 		1 903
1 711
11.22%		953
1 133
-15.93%		1 452
1 453
-0.09%		1 938
1 681
15.27%		1 345
1 544
-12.9%		1 763
1 660
6.22%		-57,4
-813
92.94%		2 190
1 811
20.89%		2 243
2 058
8.99%
2 477


3 249


4 025







EPS
USD		Released
Forecast
Spread


1,05
1,85
-43.24%		1,61
1,90
-15.26%		2,14
1,78
20.22%		1,49
2,04
-26.96%		1,95
1,81
7.73%		-0,06
-0,66
90.91%		2,42
2,26
7%		2,48
2,44
1.64%
2,77


3,60


4,46







Announcement Date28/04/2204/08/2201/11/2202/02/2327/04/2308/08/2302/11/2306/02/2430/04/24-----

Upcoming sector events for Eli Lilly and Company

2024-07-03 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
2024-07-10 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
2024-07-15 CAMURUS AB: Q2 2024 Earnings Release
2024-07-16 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-17 06:45 JOHNSON & JOHNSON: Q2 2024 Earnings Release
2024-07-17 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-18 01:00 NOVARTIS AG: Q2 2024 Earnings Release
2024-07-21 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-21 ALMIRALL, S.A.: Q2 2024 Earnings Release
2024-07-22 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Eli Lilly and Company

2024-06-21 11:28 DEVA HOLDING: Q1 2024 Earnings Release
2024-06-13 17:21 EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release
2024-06-11 01:30 BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release
2024-06-07 06:33 SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release
2024-06-07 05:17 LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release
2024-05-30 08:08 SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-30 07:00 ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
2024-05-30 02:24 MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-29 08:00 FDC LIMITED: Q4 2024 Earnings Release
2024-05-29 05:26 JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. LLY Stock
  4. LLY Stock
  5. Calendar Eli Lilly and Company